Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...
AppLovin Corp (NASDAQ:APP), with a market capitalization of $126.9 billion, reported its Q4 2024 earnings, surpassing Wall Street expectations with an earnings per share (EPS) of $1.73 against a ...